An update on COVID-19 for the radiologist - A British society of Thoracic Imaging statement

Rodrigues, Jonathan; Hare, S.S.; Edey, Anthony; Devaraj, Anand; Jacob, Joseph; Johnstone, Annette; McStay, R.; Nair, Arjun; Robinson, Graham

doi:10.1016/j.crad.2020.03.003

Cited by 207 publications

(222 citation statements)

References 15 publications

Supporting

Mentioning

202

Contrasting

Unclassified

Order By: Relevance

“…The developed chest CT table which is advised by British Society of Thoracic Imaging (BTSI) could make classifications at 4 stages. This classification has been adopted by many radiologists in Turkey (Table 1) [10,11].…”

Section: Radiological Findings and Classificationmentioning

confidence: 99%

Radiological approaches to COVID-19 pneumonia

Akçay¹,

Özlü²,

Yılmaz³

2020

Turk J Med Sci

View full text Add to dashboard Cite

show abstract

Section: Radiological Findings and Classificationmentioning

confidence: 99%

Radiological approaches to COVID-19 pneumonia

Akçay¹,

Özlü²,

Yılmaz³

2020

Turk J Med Sci

View full text Add to dashboard Cite

show abstract

“…Therefore, pulmonary CT angiography is essential for evaluating lung parenchyma and vascular complications for COVID-19 cases with severe and/or critical clinical features and high D-dimer levels(Figures 6a, 6b, and 6c). Recently, the British Thoracic Imaging Association has suggested that if pulmonary CT angiography (CTA) is required in a potential COVID-19 patient, prior to CTA, an unenhanced chest CT should be performed because mosaic attenuation in CTA can be confused with GGO[48].…”

mentioning

confidence: 99%

Chest CT features of the novel coronavirus disease (COVID-19)

Ufuk¹,

Savaş²

2020

Turk J Med Sci

View full text Add to dashboard Cite

A new type of coronavirus (2019-nCoV) is rapidly spreading worldwide and causes pneumonia, respiratory distress, thromboembolic events, and death. Chest computed tomography (CT) plays an essential role in the diagnosis of viral pneumonia, monitoring disease progression, determination of disease severity, and evaluating therapeutic efficacy. Chest CT can show important clues of 2019-nCoV disease (also known as COVID-19) in patients with an appropriate clinic. Prompt diagnosis of COVID-19 is essential to prevent disease transmission and provides close clinical observation of patients with clinically severe disease. Therefore, radiologists and clinicians should be familiar with the CT imaging findings of COVID-19 pneumonia. Herein, we aimed to review the imaging findings of COVID-19 pneumonia and examine the critical points to be considered for imaging in cases with COVID-19 suspicion.

show abstract

“…Moderate anaemia (haemoglobin 107 g/l) and marked leucocytopenia (white blood cell count 1300/l, neutrophils 600/l, lymphocytes 600/l) with platelets <90 × 10 9 /l and CRP 1.3 mg/l. An anteroposterior chest x-ray with the patient in bed and in the supine position, showed "asymmetric" and bilateral diffuse "patchy" parenchymal opacities [22], more marked in the left hemithorax where they were present from the apex to the base (fig. 1).…”

Section: Diagnostic Workupmentioning

confidence: 99%

Benign COVID-19 in an immunocompromised cancer patient - the case of a married couple

Spezzani

Piunno

Iselin³

2020

Swiss Med Wkly

View full text Add to dashboard Cite

Respiratory failure in COVID-19 is a common feature in fatal cases and has been considered as a failure of the immune system to control the virus. Here we report the case of COVID-19 affecting an immunocompromised women and her presumably immunocompetent spouse. A married couple (age 60 years) was simultaneously admitted to the emergency department on 10 March 2020 because of dyspnoea and fever, consistent with COVID-19. The wife (patient 1) was partially immunocompromised as a consequence of a recently started chemotherapy with fulvestrant and abemaciclid for recurring breast cancer, her husband (patient 2) had been healthy except for a history of controlled arterial hypertension. Both patients were treated with darunavir/cobicistat and hydroxychloroquine. The clinical course of the immunocompromised partner was benign, without need of intensive care. She was able to leave the hospital on day 6 after admission. In contrast, her husband needed intensive care and his recovery was slow, although eventually successful too. These findings suggest that the course of COVID-19 is not necessarily ominous in the presence of a compromised immune response and tend to reinforce the emerging therapeutic concepts of a controlled mitigation of the immune cascade following SARS CoV-2 infection.

show abstract

An update on COVID-19 for the radiologist - A British society of Thoracic Imaging statement

Cited by 207 publications

References 15 publications

Radiological approaches to COVID-19 pneumonia

Radiological approaches to COVID-19 pneumonia

Chest CT features of the novel coronavirus disease (COVID-19)

Benign COVID-19 in an immunocompromised cancer patient - the case of a married couple

Contact Info

Product

Resources

About